169 related articles for article (PubMed ID: 4644642)
1. An overview of the analysis and interpretation of bioavailability studies in man.
Wagner JG
Pharmacology; 1972; 8(1):102-17. PubMed ID: 4644642
[No Abstract] [Full Text] [Related]
2. Keeping bioavailability in perspective.
Schumacher GE
Am J Hosp Pharm; 1973 Feb; 30(2):150-4. PubMed ID: 4690469
[No Abstract] [Full Text] [Related]
3. An overview of the analysis and interpretation of bioavailability studies in man.
Wagner JG
Arzneimittelforschung; 1976; 26(1A):105-8. PubMed ID: 947190
[TBL] [Abstract][Full Text] [Related]
4. Novel method for bioavailability assessment.
Kwan KC; Till AE
J Pharm Sci; 1973 Sep; 62(9):1494-7. PubMed ID: 4743100
[No Abstract] [Full Text] [Related]
5. Bioavailability of drugs (second of two parts).
Koch-Weser J
N Engl J Med; 1974 Sep; 291(10):503-6. PubMed ID: 4604153
[No Abstract] [Full Text] [Related]
6. Bioavailability of drugs (first of two parts).
Koch-Weser J
N Engl J Med; 1974 Aug; 291(5):233-7. PubMed ID: 4600408
[No Abstract] [Full Text] [Related]
7. Transfer functions obtained by the rule of corresponding fractional areas.
Dost FH; von Hattingberg HM
Eur J Clin Pharmacol; 1971 Sep; 3(4):252-4. PubMed ID: 5151310
[No Abstract] [Full Text] [Related]
8. Absorption of digoxin from different oral preparations in normal subjects during steady state.
Huffman DH; Manion CV; Azarnoff DL
Clin Pharmacol Ther; 1974 Aug; 16(2):310-7. PubMed ID: 4850376
[No Abstract] [Full Text] [Related]
9. [A pharmacokinetic function for galenics].
Dost FH
Arzneimittelforschung; 1971 May; 21(5):712-7. PubMed ID: 5109699
[No Abstract] [Full Text] [Related]
10. Non-equivalence of digoxin tablets.
Reissell P; Manninen V; Ojala K; Karjalainen J
Ann Clin Res; 1974; 6(0):suppl 11:4-8. PubMed ID: 4853359
[No Abstract] [Full Text] [Related]
11. [Methodological approach to the measure of the bioavailability of drugs in man (author's transl)].
Lesne M
J Pharm Belg; 1976; 31(1):5-24. PubMed ID: 768445
[No Abstract] [Full Text] [Related]
12. Bioavailability of digoxin: what the clinician needs to know.
Greenblatt DJ; Duhme DW; Koch-Weser J; Smith TW
Conn Med; 1974 May; 38(5):230-2. PubMed ID: 4831099
[No Abstract] [Full Text] [Related]
13. [Pharmacokinetic models].
Dahl S
Tidsskr Nor Laegeforen; 1973 Jan; 93(3):157-62. PubMed ID: 4693373
[No Abstract] [Full Text] [Related]
14. Evaluation of digoxin bioavailability in single-dose studies.
Greenblatt DJ; Duhme DW; Koch-Weser J; Smith TW
N Engl J Med; 1973 Sep; 289(13):651-4. PubMed ID: 4727968
[No Abstract] [Full Text] [Related]
15. Application of pharmacokinetics and biopharmaceutics in the design of toxicological studies.
Smyth RD; Hottendorf GH
Toxicol Appl Pharmacol; 1980 Apr; 53(2):179-95. PubMed ID: 7394763
[No Abstract] [Full Text] [Related]
16. The bioavailability of digoxin.
Lancet; 1972 Aug; 2(7772):311-2. PubMed ID: 4115037
[No Abstract] [Full Text] [Related]
17. Influence of first-pass effect on availability of drugs on oral administration.
Gibaldi M; Boyes RN; Feldman S
J Pharm Sci; 1971 Sep; 60(9):1338-40. PubMed ID: 5567579
[No Abstract] [Full Text] [Related]
18. Bioavailability, clinical effectiveness, and the public interest.
Levy G
Pharmacology; 1972; 8(1):33-43. PubMed ID: 4644654
[No Abstract] [Full Text] [Related]
19. Drug doses for children. A rational approach to an old problem.
Habersang R; Kauffman RE
J Kans Med Soc; 1974 Mar; 75(3):98-103. PubMed ID: 4593019
[No Abstract] [Full Text] [Related]
20. Bioavailability of digoxin in man after oral administration of preparations with different dissolution rate.
Nyberg L
Acta Pharmacol Toxicol (Copenh); 1977; 40 Suppl 3():1-48. PubMed ID: 301340
[No Abstract] [Full Text] [Related]
[Next] [New Search]
